In terms of revenue, Global Glioblastoma Multiforme Treatment Market is expected to grow at a CAGR of 12.67% over the forecast period (2021 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries. Absolute Markets Insights has announced addition of an insightful analytical data to its massive repository titled Glioblastoma Multiforme Treatment Market. Global competitors also highlighted in the study in order to get a stronger and effective outlook of the competition at domestic as well as global regions. In addition, the report also provides comprehensive information based on primary and secondary research methods for accurate data exploration.
Key Companies Profiled: Merck & Co. Inc., Amgen Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., DelMar Pharmaceuticals, NOXXON Pharma, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals, Amneal Pharmaceuticals, Karyopharm Therapeutics Inc, Sumitomo Dainippon Pharma Oncology
Get a link for more details of market report at @https://www.absolutemarketsinsights.com/reports/Global-Glioblastoma-Multiforme-Treatment-Market-2021—2029-923
Though the treatment of glioblastoma multiforme is complex in nature, and is associated with limited success, there are multiple treatment types available in the global glioblastoma multiforme treatment market. They include surgery, radiotherapy, chemotherapy, tumor treating fields (TTF) therapy, targeted drug therapy, amongst others. The most common treatment method is the surgical removal of tumor cells, which is followed by radiotherapy and chemotherapy. In surgery, the main objective is the removal of a large chunk of tumor cells without damaging the neighbouring brain tissue which are pivotal for the normal functioning of the nervous system. The complete removal of the GBM is considered impossible, as tumor is surrounded by a section of migrating cells that invade the surrounding brain tissues. Surgery is mainly used for the debulking of the growth, and it has the potential to extend the lives of some patients, and provide a higher quality of remaining life.
As far as the regions in the global glioblastoma multiforme treatment market are concerned, North America was the prominent region in terms of revenue in 2020. The advancement in medical care technology in the U.S. and Canada, coupled with the presence of medical conglomerates such as Pfizer, Roche and Merck, amongst others is a major reason for the higher share of North America in the global glioblastoma multiforme treatment market. Amgen, for instance, provides an antiangiogenic that blocks signalling of angiopoietin-Tie2, and limits the growth endothelial cells associated with the tumor.
The report provides both, qualitative and quantitative research of global glioblastoma multiforme treatment market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Glioblastoma Multiforme Treatment Market Segmentation:
By Type of Treatment
- Surgery
- Radiotherapy
- Chemotherapy
- Tumor treating fields (TTF) therapy
- Targeted drug therapy
- Supportive (palliative) care
- Others
By Mode of Action
- Immunological
- Metabolic
- Pharmacological
By Demographic
- Kids
- Adults
By End Users
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical Companies
- Others
By Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin Americ
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-740-024-2424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com
